Morgan Stanley Starts Biogen (BIIB) at Overweight
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $216.65 -0.85%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 17
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 17
Join SI Premium – FREE
Morgan Stanley initiates coverage on Biogen (NASDAQ: BIIB) with a Overweight. PT $140.00.
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $117.78 yesterday.
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $117.78 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rosenblatt Starts Booking Holdings (BKNG) at Buy
- Danske Bank A/S (DANSKE:DC) (DNKEY) PT Raised to DKK436 at Morgan Stanley
- Deutsche Bank Starts SPIE SA (SPIE:FP) (SPIWF) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
